Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 2011; Volume 79,Issue 6

Articles

  • You have access
    Negative Gating Modulation by (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) Depends on Residues in the Inner Pore Vestibule: Pharmacological Evidence of Deep-Pore Gating of KCa2 Channels
    David Paul Jenkins, Dorte Strøbæk, Charlotte Hougaard, Marianne L. Jensen, Rene Hummel, Ulrik S. Sørensen, Palle Christophersen and Heike Wulff
    Molecular Pharmacology June 2011, 79 (6) 899-909; DOI: https://doi.org/10.1124/mol.110.069807
  • You have access
    Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
    Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Kimon C. Kanelakis, Xiaodong Wu, Peter V. Haug, Wen Yan, Andrew Young, Hong Hua, Juliet C. Hart, Da-Thao Tran, Hariharan Venkatesan, Mark D. Rosen, Hillary M. Peltier, Kia Sepassi, Michele C. Rizzolio, Scott D. Bembenek, Tara Mirzadegan, Michael H. Rabinowitz and Nigel P. Shankley
    Molecular Pharmacology June 2011, 79 (6) 910-920; DOI: https://doi.org/10.1124/mol.110.070508
  • You have access
    The Potent and Novel Thiosemicarbazone Chelators Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-Benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone Affect Crucial Thiol Systems Required for Ribonucleotide Reductase Activity
    Yu Yu, Yohan Suryo Rahmanto, Clare L. Hawkins and Des R. Richardson
    Molecular Pharmacology June 2011, 79 (6) 921-931; DOI: https://doi.org/10.1124/mol.111.071324
  • You have access
    Poly(ADP-ribose) Polymerase-1 Is a Nuclear Epigenetic Regulator of Mitochondrial DNA Repair and Transcription
    Andrea Lapucci, Maria Pittelli, Elena Rapizzi, Roberta Felici, Flavio Moroni and Alberto Chiarugi
    Molecular Pharmacology June 2011, 79 (6) 932-940; DOI: https://doi.org/10.1124/mol.110.070110
  • You have access
    Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Inhibition by 4-Hydroxynonenal Leads to Increased Akt Activation in Hepatocytes
    Colin T. Shearn, Rebecca L. Smathers, Benjamin J. Stewart, Kristofer S. Fritz, James J. Galligan, Numsen Hail and Dennis R. Petersen
    Molecular Pharmacology June 2011, 79 (6) 941-952; DOI: https://doi.org/10.1124/mol.110.069534
  • You have access
    RNA-Induced Silencing Complex-Bound Small Interfering RNA Is a Determinant of RNA Interference-Mediated Gene Silencing in Mice
    Jie Wei, Jeffrey Jones, Jing Kang, Ananda Card, Michael Krimm, Paula Hancock, Yi Pei, Brandon Ason, Elmer Payson, Natalya Dubinina, Mark Cancilla, Mark Stroh, Julja Burchard, Alan B. Sachs, Jerome H. Hochman, W. Michael Flanagan and Nelly A. Kuklin
    Molecular Pharmacology June 2011, 79 (6) 953-963; DOI: https://doi.org/10.1124/mol.110.070409
  • You have access
    Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
    Ana María Martín-Moreno, David Reigada, Belén G. Ramírez, R. Mechoulam, Nadia Innamorato, Antonio Cuadrado and María L. de Ceballos
    Molecular Pharmacology June 2011, 79 (6) 964-973; DOI: https://doi.org/10.1124/mol.111.071290
  • You have access
    Glycogen Synthase Kinase-3β Is a Functional Modulator of Serotonin-1B Receptors
    L. Chen, W. Zhou, P. C. Chen, I. Gaisina, S. Yang and X. Li
    Molecular Pharmacology June 2011, 79 (6) 974-986; DOI: https://doi.org/10.1124/mol.111.071092
  • You have access
    Regulation of Calcium Channels and Exocytosis in Mouse Adrenal Chromaffin Cells by Prostaglandin EP3 Receptors
    Mark L. Jewell, Richard M. Breyer and Kevin P. M. Currie
    Molecular Pharmacology June 2011, 79 (6) 987-996; DOI: https://doi.org/10.1124/mol.110.068569
  • You have access
    The Bcl-2 Homology Domain 3 (BH3) Mimetic ABT-737 Reveals the Dynamic Regulation of Bad, a Proapoptotic Protein of the Bcl-2 Family, by Bcl-xL
    Zakaria Ezzoukhry, Christophe Louandre, Catherine François, Zuzana Saidak, Corinne Godin, Jean-Claude Mazière and Antoine Galmiche
    Molecular Pharmacology June 2011, 79 (6) 997-1004; DOI: https://doi.org/10.1124/mol.110.070565
  • You have access
    PMX-53 as a Dual CD88 Antagonist and an Agonist for Mas-Related Gene 2 (MrgX2) in Human Mast Cells
    Hariharan Subramanian, Sakeen W. Kashem, Sarah J. Collington, Hongchang Qu, John D. Lambris and Hydar Ali
    Molecular Pharmacology June 2011, 79 (6) 1005-1013; DOI: https://doi.org/10.1124/mol.111.071472
  • You have access
    Galangin Suppresses the Proliferation of β-Catenin Response Transcription-Positive Cancer Cells by Promoting Adenomatous Polyposis Coli/Axin/Glycogen Synthase Kinase-3β-Independent β-Catenin Degradation
    Jungsug Gwak, Jingyo Oh, Munju Cho, Soo Kyung Bae, Im-Sook Song, Kwang-Hyeon Liu, Yongsu Jeong, Dong-Eun Kim, Young-Hwa Chung and Sangtaek Oh
    Molecular Pharmacology June 2011, 79 (6) 1014-1022; DOI: https://doi.org/10.1124/mol.110.069591
  • You have access
    Rapid and Contrasting Effects of Rosiglitazone on Transient Receptor Potential TRPM3 and TRPC5 Channels
    Yasser Majeed, Yahya Bahnasi, Victoria A. L. Seymour, Lesley A. Wilson, Carol J. Milligan, Anil K. Agarwal, Piruthivi Sukumar, Jacqueline Naylor and David J. Beech
    Molecular Pharmacology June 2011, 79 (6) 1023-1030; DOI: https://doi.org/10.1124/mol.110.069922
  • You have access
    Selective Toxicity of the Anthelmintic Emodepside Revealed by Heterologous Expression of Human KCNMA1 in Caenorhabditis elegans
    Anna Crisford, Caitriona Murray, Vincent O'Connor, Richard J. Edwards, Nina Kruger, Claudia Welz, Georg von Samson-Himmelstjerna, Achim Harder, Robert J. Walker and Lindy Holden-Dye
    Molecular Pharmacology June 2011, 79 (6) 1031-1043; DOI: https://doi.org/10.1124/mol.111.071043
  • You have access
    G Protein-Coupled Receptor Heteromerization: A Role in Allosteric Modulation of Ligand Binding
    Ivone Gomes, Adriaan P. IJzerman, Kai Ye, Emeline L. Maillet and Lakshmi A. Devi
    Molecular Pharmacology June 2011, 79 (6) 1044-1052; DOI: https://doi.org/10.1124/mol.110.070847
  • You have access
    Inhibition of Human UGT2B7 Gene Expression in Transgenic Mice by the Constitutive Androstane Receptor
    M. F. Yueh, P. L. Mellon and R. H. Tukey
    Molecular Pharmacology June 2011, 79 (6) 1053-1060; DOI: https://doi.org/10.1124/mol.110.070649
  • You have access
    κ-Opioid Receptor Inhibition of Calcium Oscillations in Spinal Cord Neurons
    Lakshmi Kelamangalath, Shashank M. Dravid, Joju George, Jane V. Aldrich and Thomas F. Murray
    Molecular Pharmacology June 2011, 79 (6) 1061-1071; DOI: https://doi.org/10.1124/mol.111.071456
  • You have access
    Bcl-xL Is a Dominant Antiapoptotic Protein that Inhibits Homoharringtonine-Induced Apoptosis in Leukemia Cells
    Shiliang Yin, Rui Wang, Fan Zhou, Hong Zhang and Yongkui Jing
    Molecular Pharmacology June 2011, 79 (6) 1072-1083; DOI: https://doi.org/10.1124/mol.110.068528
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 79 (6)
Molecular Pharmacology
Vol. 79, Issue 6
1 Jun 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics